Investor Information
At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.
Disclosure Under Regulation 30
| Particulars | Date |
|---|---|
| Intimation of Update on Acquisition - Pharmazz Inc. | 23 May 2025 |
| Stock Exchange Letter Disclosure of Q4FY25 Earnings Call Audio Recording | 22 May 2025 |
| Intimation of Record Date for the purpose of Final Dividend | 22 May 2025 |
| Intimation of Change in Director(s) | 22 May 2025 |
| Intimation of Appointment of Secretarial Auditor | 22 May 2025 |
| Intimation of Schedule of Analyst/Institutional Investor Meeting | 20 May 2025 |
| Intimation of Press Release | 16 May 2025 |
| Intimation of Change in Key Managerial Personnel - Chief Financial Officer | 06 May 2025 |
| Intimation of Press Release | 24 April 2025 |
| Intimation of Order Vacating Preliminary Injunction on LEQSELVI™ | 10 April 2025 |